EUVIMED · CrossrefJournal
PharmacoEconomics
ISSN 1170-7690 · Springer Science and Business Media LLC
Latest articles
The Accumulation of Healthcare, Benefit and Social Care Costs of Depression Before and After Diagnosis: A Six-Year Observational Cohort Study
Economic Evaluation Models of Specialty Disease-Modifying Anti-rheumatic Drugs After Failure of Conventional Therapies: A Systematic Review
Response to Comment on “Valuation of EQ-5D-5L Health States in Poland: The First EQ-VT-Based Study in Central and Eastern Europe”
Comment on “Valuation of EQ-5D-5L Health States in Poland: The First EQ-VT-Based Study in Central and Eastern Europe”
Constructing a US Value Set for Child Health States: The PedsUtil Scoring System
A Systematic Literature Review on the Economic Burden of Sjögren’s Disease
Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Practical Guidance
Uncertainty in Economic Evaluation: A Pragmatic Guide for Health Technology Assessment (HTA) Agencies in Resource-Constrained Settings
Cost-Utility Analyses of Systemic Treatments for Psoriasis and Psoriatic Arthritis in the UK: A Systematic Review of Modelling Methods
Accounting for Oral Corticosteroids Tapering and Reduction in Adverse Effect Burden in Health Economic Evaluations: External Assessment Group Perspective
Identifying and Comparing Intervention Cost Components in Remote Patient Monitoring: A Scoping Review
Informing the Equitable Implementation of Hepatitis C Interventions: Cost-Effectiveness Modeling in Rural Populations of People Who Inject Drugs
Real-World Economic Burden Associated with Progressive Pulmonary Fibrosis in the US: An Administrative Claims Database Analysis
Cost-Utility Analysis of Calcitonin Gene-Related Peptide Monoclonal Antibodies for Patients with Episodic Migraine Headache in the USA
Deriving a Korean SF-6Dv2 Value Set Using a Discrete Choice Experiment with Duration
Cost-Effectiveness Analysis of Low-Dose Atropine Eye Drops (0.01%) for the Treatment of Myopia in Children: A United Kingdom Perspective
A Critical Systematic Review of Modelling Approaches and Methodologies used in Hyperlipidaemia Economic Evaluations
Correction: Development of a Patient-Level Multi-objective Optimisation Model for Screening Strategies for Childhood Type 1 Diabetes
Utilization and Lifetime Costs of Formal Care for Alzheimer’s Disease Dementia in Sweden
Developing French Population Tariffs for the ICECAP-A Using Best–Worst Scaling
Balancing Innovation and Access: Insights from AIM’s Fair Pricing Model and Its Current and Future Applications
Application of a Prevalence-Adjusted Cost-Effectiveness Threshold Framework for Pulmonary Arterial Hypertension
Comparison of Alternative Outcome Measures in Cost-Effectiveness Analysis: Three Applications Within Oncology
Using Proportional and Absolute Shortfall in Reimbursement Decision-Making in the Netherlands: Implications for Oncology Drugs for Older Patients
Economic Evaluation of the Addition of Vancomycin to Cefazolin Prophylaxis in Patients Undergoing Arthroplasty
The Economic Burden of Duchenne Muscular Dystrophy: A Systematic Review
What is the Value of Developing an HTA Process?
Correction: Ten Recommendations for Modelling Cost Effectiveness of Screening: Perspectives of an International Stakeholder Group
Component Clinical and Cost Outcomes Complementing Value of Information: Case Study of a Tuberculosis Diagnostics Clinical Trial
Public Health Impact and Cost-Effectiveness of Revising the Adolescent Meningococcal Vaccine Schedule in the United States
Volumes
2026 · 1372025 · 1102024 · 1162023 · 1062022 · 1232021 · 1142020 · 1192019 · 1332018 · 1292017 · 1172016 · 1152015 · 1062014 · 1112013 · 1012012 · 952011 · 882010 · 1142009 · 922008 · 862007 · 862006 · 1402005 · 1142004 · 1252003 · 1072002 · 1032001 · 1052000 · 1131999 · 1311998 · 1541997 · 1521996 · 1811995 · 1331994 · 1751993 · 1071992 · 150
EUVIMED